Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
planB: Adjuvant TC vs EC-Docetaxel in HER2-negative Breast Cancer
NCT01049425Phase 3Completed
- Sponsor
- Westdeutsche Studiengruppe
- Start
- Feb 2009
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel, cyclophosphamide in breast cancer, sponsored by Westdeutsche Studiengruppe. Started Feb 2009; status: completed.
02
Drugs
docetaxelcyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01049425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01049425.